Xeris Pharmaceuticals Inc (XERS) — Cash Flow Reinvestment Rate
Xeris Pharmaceuticals Inc (XERS) has a Cash Flow Reinvestment Rate of 0.02x as of December 2025, reinvesting $333.00K (capex $333.00K ) from operating cash flow of $20.04 Million. Explore XERS capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xeris Pharmaceuticals Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Xeris Pharmaceuticals Inc across 1 annual periods. Also explore XERS asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Xeris Pharmaceuticals Inc (2025–2025)
Year-by-year capital reinvestment analysis for Xeris Pharmaceuticals Inc. For live market cap and broader valuation context, see market cap of Xeris Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.02x | $696.00K | $28.63 Million | $696.00K | — |